On the one hand, two studies on patient-derived ovarian cancer organoids and glioblastoma SCs reported that CSCs efficiently resolve RS [41, 43], in line with a large body of literature showing proficient ATR-CHK1 cascade activation by RS inducers in multiple CSC types [27]. The gene discussed is CHEK1; the disease is ovarian cancer.